𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis

✍ Scribed by Tousif Pasha; Jenny Heathcote; Sherine Gabriel; Karen Cauch-Dudek; Roberta Jorgensen; Terry Therneau; E. Rolland Dickson; Keith D. Lindor

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
189 KB
Volume
29
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Biliary bile acids in primary biliary ci
Biliary bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid
✍ Burton Combes; Robert L. Carithers Jr.; Willis C. Maddrey; Santiago Munoz; Guada πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

Bile acid composition in fasting duodenal bile was assessed at entry and at 2 years in patients with primary biliary cirrhosis (PBC) enrolled in a randomized, doubleblind, placebo-controlled trial of ursodeoxycholic acid (UDCA) (10-12 mg/kg/d) taken as a single bedtime dose. Specimens were analyzed

Effect of pretransplantation ursodeoxych
Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis
✍ Heathcote, E. Jenny ;Stone, Julie ;Cauch-Dudek, Karen ;Poupon, Raoul ;Chazouille πŸ“‚ Article πŸ“… 1999 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 42 KB πŸ‘ 1 views

As ursodeoxycholic acid (UDCA) delays the need for transplantation, this could result in patients with more comorbid disease, therefore more likely to have a worse outcome posttransplantation. The aim of this study is to compare posttransplantation outcome in patients who received UDCA versus placeb

Long-term ursodeoxycholic acid delays hi
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
✍ Paul Angulo; Kenneth P. Batts; Terry M. Therneau; Roberta A. Jorgensen; E. Rolla πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 50 KB πŸ‘ 1 views

Primary biliary cirrhosis (PBC) is a progressive cholestatic liver disease frequently leading to development of cirrhosis and its complications. Ursodeoxycholic acid (UDCA) is a beneficial medical therapy for patients with PBC. Improvement in some histological features, but not in histological stage

Ursodeoxycholic acid inhibits eosinophil
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis
✍ Kiyoshi Yamazaki; Kazuyuki Suzuki; Atsushi Nakamura; Shunichi Sato; Keith D. Lin πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 421 KB πŸ‘ 1 views

Eosinophilia is a distinctive feature of primary biliary cirrhosis (PBC), especially in its early stages. Intriguingly, treatment with ursodeoxycholic acid (UDCA) ameliorates eosinophilia as well as liver tests in patients with PBC. It remains unknown, however, whether eosinophils in PBC patients ar

Ursodeoxycholic acid in the treatment of
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: First controlled data
✍ Marie Borum; Hans Fromm πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 280 KB πŸ‘ 1 views

There is no doubt that further investigations of this phenomenon will be performed and published promptly. Until these questions are answered, we may appreciate the accuracy of Ogden Nash's old observation that "While candy is dandy, liquor is quicker!" 1.